INBS — Intelligent Bio Solutions Share News
0.000.00%
Last trade - 00:00- $5.27m
- $1.06m
- $4.22m
Brief: GBS Reports Second Quarter 2022 Financial Results And Recent Business Highlights
Brief: GBS Inc Announces Application For FDA Breakthrough Device Designation To Fast Track Rapid Saliva Glucose Test
Brief: GBS Inc. Announces Plans For Clinical Sars-Cov-2 Antibody Trials Following Validation Study
Brief: GBS Posts Q1 Preliminary Loss Per Share Of $0.10
Brief: Gbs Inc Announces Its Pre-Submission Package Is With The FDA
U.S. STOCKS ON THE MOVE-Anaplan, Nio, Corteva, copper miners
Brief: GBS Says L.E.K. To Shortlist Within Two Months Commercial Partners In China
GBS Inc: Jumps on Australian grant to manufacture biosensor technology
Brief: GBS Awarded $4.7 Million Australian Federal Government Science Grant To Manufacture Biosensor Technology
Brief: GBS Inc - Qtrly Loss Per Share Of $0.27
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:07 PM
GBS Inc: Slumps in Nasdaq debut
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM